Richard Aguilar is Chief Clinical Officer at Cano Health, Inc. (CANO). They have made 6 open-market trades across 1 company since 2021, most recently 2023-06-29.
CIK 0001865481
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $10.2M since 2021, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CANO | 1,213,984 | $2.8M |
Shares reported on the most recent Form 4, priced at the 2023-06-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CANO | SELL | 2023-06-28 | 2023-06-30 | $1.29 | $707K | +0.7% | +5.8% | -79.7% |
| CANO | SELL | 2023-06-07 | 2023-06-13 | $1.35 | $2.1M | -9.8% | +5.3% | -73.0% |
| CANO | SELL | 2023-04-05 | 2023-04-06 | $0.00 | $0 | +0.8% | -10.4% | +2.4% |
| CANO | BUY | 2021-08-30 | 2021-09-01 | $11.93 | $21K | +2.9% | -2.7% | -31.4% |
| CANO | BUY | 2021-08-30 | 2021-09-14 | $10.75 | $266K | -1.3% | -16.6% | -34.3% |
| CANO | BUY | 2021-08-25 | 2021-08-31 | $11.08 | $10.0M | +12.0% | +2.8% | -23.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.